CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $814,975
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-12 | D'Alvise Janelle PRESIDENT & CEO | Grant or award · Stock Options (Right to Buy) | +655,500 | 655,500 | ||
| 2021-11-12 | Carter Roderick Noel Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 | ||
| 2021-11-12 | Canan John Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 |
Page 5 of 5 · 83 trades